Rhumbline Advisers Pulmonx Corp Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Pulmonx Corp stock. As of the latest transaction made, Rhumbline Advisers holds 51,015 shares of LUNG stock, worth $341,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,015

Previous 51,706 1.34%

Holding current value

$341,800

Previous $327,000 29.05%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$5.59 - $8.58 $3,862 - $5,928	-691 Reduced 1.34%	51,015 $422,000
Q2 2024 Aug 01, 2024	SELL	$5.77 - $9.82 $5,400 - $9,191	-936 Reduced 1.78%	51,706 $327,000
Q1 2024 May 09, 2024	BUY	$8.71 - $14.65 $15,103 - $25,403	1,734 Added 3.41%	52,642 $487,000
Q4 2023 Feb 08, 2024	BUY	$7.89 - $13.14 $15,598 - $25,977	1,977 Added 4.04%	50,908 $649,000
Q3 2023 Nov 09, 2023	SELL	$9.88 - $14.0 $12,103 - $17,150	-1,225 Reduced 2.44%	48,931 $505,000
Q2 2023 Aug 08, 2023	BUY	$10.78 - $13.65 $52,455 - $66,420	4,866 Added 10.74%	50,156 $657,000
Q1 2023 May 11, 2023	BUY	$7.49 - $12.54 $11,856 - $19,850	1,583 Added 3.62%	45,290 $506,000
Q4 2022 Feb 14, 2023	BUY	$4.92 - $17.35 $6,710 - $23,665	1,364 Added 3.22%	43,707 $368,000
Q3 2022 Nov 10, 2022	BUY	$15.35 - $23.99 $47,477 - $74,201	3,093 Added 7.88%	42,343 $705,000
Q2 2022 Aug 11, 2022	BUY	$14.0 - $27.95 $175,686 - $350,744	12,549 Added 47.0%	39,250 $578,000
Q1 2022 May 12, 2022	BUY	$21.13 - $35.65 $34,167 - $57,646	1,617 Added 6.45%	26,701 $662,000
Q4 2021 Feb 10, 2022	SELL	$29.72 - $45.1 $15,038 - $22,820	-506 Reduced 1.98%	25,084 $804,000
Q3 2021 Nov 12, 2021	BUY	$35.98 - $44.48 $44,867 - $55,466	1,247 Added 5.12%	25,590 $921,000
Q2 2021 Aug 05, 2021	BUY	$37.61 - $48.0 $443,346 - $565,824	11,788 Added 93.89%	24,343 $1.07 Million
Q1 2021 May 06, 2021	BUY	$44.0 - $67.54 $40,392 - $62,001	918 Added 7.89%	12,555 $574,000
Q4 2020 Feb 10, 2021	BUY	$39.31 - $69.02 $457,450 - $803,185	11,637 New	11,637 $803,000

Others Institutions Holding LUNG

# of Institutions

124

Shares Held

31M

Call Options Held

300

Put Options Held

204K

View Full List

About Pulmonx Corp

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $250M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

More about LUNG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Pulmonx Corp Transaction History